More patients can benefit from existing breast cancer drugs

被引：0
|
作者：
Printz, Carrie
机构：
来源：
CANCER | 2013年 / 119卷 / 08期
关键词：
D O I：
10.1002/cncr.28070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1449 / 1449
页数：1
相关论文
共 50 条
  • [21] Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients
    Freedman, Orit
    Amir, Eitan
    Dranitsaris, George
    Napolskikh, Julie
    Kumar, Ritu
    Fralick, Michael
    Chia, Stephen
    Petrella, Teresa
    Dent, Susan
    Tonkin, Katia
    Ahmad, Imran
    Rayson, Daniel
    Clemons, Mark
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (02) : 377 - 383
  • [22] Characteristics of breast cancer patients unlikely to benefit from adjuvant therapy
    Ejlertsen, B.
    Christiansen, P.
    Bjerre, K.
    Jensen, M. B.
    Rasmussen, B. B.
    Laenkholm, A. V.
    Kroman, N.
    Kvistgaard, M. E.
    Offersen, B.
    Toftdahl, D. B.
    Moller, S.
    Mouridsen, H. T.
    BREAST, 2011, 20 : S14 - S14
  • [23] Can Acupuncture Keep Women on Their Breast Cancer Drugs?
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (08): : 744 - 746
  • [24] Antidiabetic Drugs in Breast Cancer Patients
    Garczorz, Wojciech
    Kosowska, Agnieszka
    Francuz, Tomasz
    CANCERS, 2024, 16 (02)
  • [25] Anticoagulation and thrombocytopenia in cancer: what more can we learn from existing randomized controlled trials
    Falanga, Anna
    Giaccherini, Cinzia
    HAEMATOLOGICA, 2024, 109 (06) : 1648 - 1650
  • [26] Estrogen and breast cancer: can less mean more?
    Bullock, Marc D.
    Silva, Andreia M.
    Calin, George A.
    CELL CYCLE, 2015, 14 (14) : 2197 - 2198
  • [27] How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy
    Gold, Deborah T.
    Alexander, Ivy M.
    Ettinger, Mark P.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1143 - 1150
  • [28] HOW CLINICIANS AND PATIENTS CAN BENEFIT FROM BETTER DATA ON LUNG CANCER
    Peake, Michael D.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S118 - S119
  • [29] Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review
    Wang, Jin
    Liao, Dongying
    Zhang, Xuemin
    Miao, Changhong
    Chen, Kuang
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 281 - 294
  • [30] Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer
    Andreetta, C.
    Puppin, C.
    Minisini, A.
    Valent, F.
    Pegolo, E.
    Damante, G.
    Di Loreto, C.
    Pizzolitto, S.
    Pandolfi, M.
    Fasola, G.
    Piga, A.
    Puglisi, F.
    ANNALS OF ONCOLOGY, 2009, 20 (02) : 265 - 271
12345